BRPI1011710B8 - composição para ser usada como uma lágrima artificial - Google Patents
composição para ser usada como uma lágrima artificialInfo
- Publication number
- BRPI1011710B8 BRPI1011710B8 BRPI1011710A BRPI1011710A BRPI1011710B8 BR PI1011710 B8 BRPI1011710 B8 BR PI1011710B8 BR PI1011710 A BRPI1011710 A BR PI1011710A BR PI1011710 A BRPI1011710 A BR PI1011710A BR PI1011710 B8 BRPI1011710 B8 BR PI1011710B8
- Authority
- BR
- Brazil
- Prior art keywords
- oil
- composition
- artificial tear
- artificial tears
- syndrome
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
lágrimas artificiais e usos trapêuticos. a presente invenção refere-se a composições oftálmicas, por exemplo lágrimas artificiais, apropriadas para o tratamento da síndrome do olho seco em um ser humano ou outro mamífero sofrendo de tal síndrome, por exemplo, um cachorro ou gato, que compreende uma mistura de óleo de mamona com outro óleo, por exemplo, um óleo alimentício, por exemplo azeite de oliva, óleo de gergelim, óleo de milho e etc.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18433909P | 2009-06-05 | 2009-06-05 | |
| US61/184,339 | 2009-06-05 | ||
| PCT/US2010/037153 WO2010141648A2 (en) | 2009-06-05 | 2010-06-03 | Artificial tears and therapeutic uses |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| BRPI1011710A2 BRPI1011710A2 (pt) | 2016-03-22 |
| BRPI1011710A8 BRPI1011710A8 (pt) | 2019-11-05 |
| BRPI1011710B1 BRPI1011710B1 (pt) | 2021-01-26 |
| BRPI1011710B8 true BRPI1011710B8 (pt) | 2021-05-25 |
Family
ID=42312750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1011710A BRPI1011710B8 (pt) | 2009-06-05 | 2010-06-03 | composição para ser usada como uma lágrima artificial |
Country Status (24)
| Country | Link |
|---|---|
| US (6) | US8496976B2 (pt) |
| EP (1) | EP2437762B1 (pt) |
| KR (1) | KR101778316B1 (pt) |
| CN (2) | CN102458430A (pt) |
| AU (1) | AU2010256652B2 (pt) |
| BR (1) | BRPI1011710B8 (pt) |
| CA (1) | CA2764802A1 (pt) |
| DK (1) | DK2437762T3 (pt) |
| ES (1) | ES2646338T3 (pt) |
| HK (1) | HK1214943A1 (pt) |
| HR (1) | HRP20171691T1 (pt) |
| HU (1) | HUE034213T2 (pt) |
| IL (1) | IL216800A (pt) |
| LT (1) | LT2437762T (pt) |
| MX (2) | MX2011013007A (pt) |
| MY (1) | MY172185A (pt) |
| NO (1) | NO2437762T3 (pt) |
| NZ (1) | NZ596932A (pt) |
| PL (1) | PL2437762T3 (pt) |
| PT (1) | PT2437762T (pt) |
| RU (1) | RU2589837C2 (pt) |
| SI (1) | SI2437762T1 (pt) |
| WO (1) | WO2010141648A2 (pt) |
| ZA (1) | ZA201108979B (pt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
| BRPI1011710B8 (pt) | 2009-06-05 | 2021-05-25 | Allergan Inc | composição para ser usada como uma lágrima artificial |
| US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
| HUE049489T2 (hu) * | 2011-12-07 | 2020-09-28 | Allergan Inc | Hatékony lipidbevitel emberi könnyfilmbe sóérzékeny emulziós rendszer alkalmazásával |
| US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| US9278132B2 (en) * | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
| US10085960B2 (en) | 2012-03-30 | 2018-10-02 | Brien Holden Vision Institute | Methods and compositions for reducing ocular discomfort |
| US9289494B2 (en) | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
| SG11201704010UA (en) | 2014-08-20 | 2017-06-29 | Silk Tech Ltd | Fibroin-derived protein composition |
| CA2967413C (en) * | 2014-11-25 | 2023-08-15 | Allergan, Inc. | Ophthalmic compositions containing omega-3 oils stabilized by antioxidants |
| WO2017066429A1 (en) | 2015-10-14 | 2017-04-20 | Paul Gavaris | Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents |
| US10953132B2 (en) | 2016-04-08 | 2021-03-23 | Cornell University | Method to enhance wound healing using silk-derived protein |
| WO2019005139A1 (en) * | 2017-06-30 | 2019-01-03 | Jenivision Inc. | FORMULATIONS FOR HAIR GROWTH |
| RS58292B1 (sr) * | 2016-07-07 | 2019-03-29 | Salvat Lab Sa | Oftalmološka kompozicija sa ricinusovim uljem i srednjim lancem triglicerida |
| CA3033507A1 (en) | 2016-08-12 | 2018-02-15 | Silk Technologies, Ltd. | Silk-derived protein for treating inflammation |
| US11903986B2 (en) * | 2016-08-19 | 2024-02-20 | Akrivista Llc | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
| GB201618175D0 (en) * | 2016-10-27 | 2016-12-14 | Warneford Healthcare Ltd | Pharmaceutical compositions |
| CN114376961A (zh) | 2017-08-18 | 2022-04-22 | 阿克里维斯塔有限责任公司 | 诊断和治疗干眼综合症的方法和用于治疗人类眼睛的组合物 |
| WO2020021481A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Vision Care, Inc. | Compositions and methods for treating the eye |
| US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| CN112739337B (zh) | 2018-07-27 | 2024-05-24 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
| US11166997B2 (en) | 2018-07-27 | 2021-11-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| EP3829614A2 (en) | 2018-07-27 | 2021-06-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| US11197841B2 (en) | 2019-07-23 | 2021-12-14 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| EP3829610A1 (en) | 2018-07-27 | 2021-06-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| US11045416B2 (en) | 2018-08-30 | 2021-06-29 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and retinol |
| US11110051B2 (en) | 2018-08-30 | 2021-09-07 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and n-acetyl glucosamine |
| KR20210009947A (ko) | 2019-07-18 | 2021-01-27 | 윤영선 | 산소가 도입된 점안제, 및 그 제조방법 |
| US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| EP3824877A1 (en) | 2019-11-19 | 2021-05-26 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating the eye |
| US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| EP3824895A1 (en) | 2019-11-19 | 2021-05-26 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating the eye |
| EP4059508A1 (en) | 2021-03-19 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Methods of using compositions comprising an iceland moss extract |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56104814A (en) * | 1980-01-25 | 1981-08-20 | Kunihiro Okanoe | Preparation of eye drop |
| US4649047A (en) | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
| ATE109970T1 (de) | 1987-09-03 | 1994-09-15 | Univ Georgia Res Found | Cyclosporin-augenmittel. |
| US4839342A (en) | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
| FR2638089A1 (fr) * | 1988-10-26 | 1990-04-27 | Sandoz Sa | Nouvelles compositions ophtalmiques a base d'une cyclosporine |
| US5474979A (en) * | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
| AU1172097A (en) | 1995-12-27 | 1997-07-28 | Rohto Pharmaceutical Co., Ltd. | Pharmaceutical composition containing trehalose |
| US5981607A (en) * | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
| GB0012597D0 (en) | 2000-05-25 | 2000-07-12 | Astrazeneca Ab | Formulation |
| US7027446B2 (en) | 2001-07-18 | 2006-04-11 | P-Cube Ltd. | Method and apparatus for set intersection rule matching |
| JP4284491B2 (ja) | 2002-07-16 | 2009-06-24 | 豊和工業株式会社 | ピストン外形の加工データ生成装置 |
| TWI335819B (en) * | 2002-12-24 | 2011-01-11 | Alcon Inc | Use of oculosurface selective glucocorticoid in the treatment of dry eye |
| RU2342953C2 (ru) * | 2003-02-24 | 2009-01-10 | Фармасьютикал Продакшенз, Инк. | Трансмукозная система доставки лекарственных средств |
| US20040185068A1 (en) | 2003-03-18 | 2004-09-23 | Zhi-Jian Yu | Self-emulsifying compositions, methods of use and preparation |
| US20060251685A1 (en) * | 2003-03-18 | 2006-11-09 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye |
| RU2007103835A (ru) | 2004-07-01 | 2008-08-10 | Шепенс Ай Рисерч (Us) | Композиции и способы лечения заболеваний и нарушений состояния глаз |
| EP1782801A4 (en) * | 2004-08-27 | 2008-08-06 | Senju Pharma Co | EYEWASH FLUID FOR THERAPY DRY EYES |
| US8569367B2 (en) * | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
| CN100562340C (zh) * | 2005-06-17 | 2009-11-25 | 中国科学院上海药物研究所 | 一种微乳型人工泪液 |
| US7297679B2 (en) | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
| US7288520B2 (en) | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
| US7202209B2 (en) | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
| WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
| WO2008027341A2 (en) * | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
| CN101668511A (zh) * | 2007-02-28 | 2010-03-10 | 阿西克斯医疗公司 | 正常化睑板腺分泌的方法和化合物 |
| CN101554369B (zh) * | 2008-05-12 | 2012-07-25 | 陈亚玲 | 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法 |
| UA36915U (uk) * | 2008-05-28 | 2008-11-10 | Львівський Національний Медичний Університет Ім. Данила Галицького | Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами |
| IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
| US9480645B2 (en) | 2009-06-02 | 2016-11-01 | Abbott Medical Optics Inc. | Omega-3 oil containing ophthalmic emulsions |
| BRPI1011710B8 (pt) | 2009-06-05 | 2021-05-25 | Allergan Inc | composição para ser usada como uma lágrima artificial |
-
2010
- 2010-06-03 BR BRPI1011710A patent/BRPI1011710B8/pt active IP Right Grant
- 2010-06-03 LT LTEP10724631.6T patent/LT2437762T/lt unknown
- 2010-06-03 DK DK10724631.6T patent/DK2437762T3/da active
- 2010-06-03 CA CA2764802A patent/CA2764802A1/en not_active Abandoned
- 2010-06-03 MX MX2011013007A patent/MX2011013007A/es active IP Right Grant
- 2010-06-03 NZ NZ596932A patent/NZ596932A/en unknown
- 2010-06-03 SI SI201031575T patent/SI2437762T1/en unknown
- 2010-06-03 PT PT107246316T patent/PT2437762T/pt unknown
- 2010-06-03 PL PL10724631T patent/PL2437762T3/pl unknown
- 2010-06-03 ES ES10724631.6T patent/ES2646338T3/es active Active
- 2010-06-03 WO PCT/US2010/037153 patent/WO2010141648A2/en active Application Filing
- 2010-06-03 US US13/376,374 patent/US8496976B2/en active Active
- 2010-06-03 HU HUE10724631A patent/HUE034213T2/en unknown
- 2010-06-03 EP EP10724631.6A patent/EP2437762B1/en not_active Revoked
- 2010-06-03 KR KR1020127000233A patent/KR101778316B1/ko active IP Right Grant
- 2010-06-03 AU AU2010256652A patent/AU2010256652B2/en active Active
- 2010-06-03 CN CN2010800348429A patent/CN102458430A/zh active Pending
- 2010-06-03 NO NO10724631A patent/NO2437762T3/no unknown
- 2010-06-03 MY MYPI2012000497A patent/MY172185A/en unknown
- 2010-06-03 CN CN201510225116.XA patent/CN104906170A/zh active Pending
- 2010-06-03 MX MX2014012100A patent/MX358504B/es unknown
- 2010-06-03 RU RU2011151468/15A patent/RU2589837C2/ru active
-
2011
- 2011-12-06 IL IL216800A patent/IL216800A/en active IP Right Grant
- 2011-12-07 ZA ZA2011/08979A patent/ZA201108979B/en unknown
-
2013
- 2013-06-28 US US13/931,281 patent/US8679554B2/en active Active
-
2014
- 2014-01-28 US US14/166,589 patent/US9821020B2/en active Active
-
2016
- 2016-03-14 HK HK16102876.7A patent/HK1214943A1/zh unknown
-
2017
- 2017-10-23 US US15/791,158 patent/US11045515B2/en active Active
- 2017-11-06 HR HRP20171691TT patent/HRP20171691T1/hr unknown
-
2021
- 2021-05-25 US US17/329,586 patent/US20220008496A1/en not_active Abandoned
-
2023
- 2023-08-03 US US18/364,692 patent/US20240108677A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1011710B8 (pt) | composição para ser usada como uma lágrima artificial | |
| BR112013007314A2 (pt) | anticorpos anti-cd48 e seus usos | |
| CL2015002519A1 (es) | Composiciones antimicrobiales y procedimientos de uso relacionados. | |
| BR112014026740A2 (pt) | anticorpo, composição, métodos para tratar um mamífero e para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo | |
| MY169328A (en) | Compositions for the treatment of dry eye | |
| GT201300209A (es) | Compuestos y composiciones como inhibidores de la trk | |
| GT201200258A (es) | Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf) | |
| UY34701A (es) | Formas sólidas de un profármaco de nucleótidos de tiofosforamidato | |
| NI201100082A (es) | Compuestos de isoindolina para uso en el tratamiento de cáncer. | |
| BR112015001847A8 (pt) | Composições e tratamento para doenças e distúrbios nos olhos | |
| BR112013006395A2 (pt) | moduladores do receptor de estrogênio e seus usos. | |
| BR112012020558A2 (pt) | moduladores do receptor de androgênio e seus usos | |
| BRPI0915536A2 (pt) | salicilatos acetilados de ácidos graxos e seus usos | |
| HN2011003011A (es) | Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas | |
| MX2011013060A (es) | Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas. | |
| BR112014033102A2 (pt) | produto para uso no tratamento profilático ou terapêutico de uma emoção negativa ou comportamento introvertido | |
| UY35073A (es) | Derivados de pirrolidinona como moduladores de GPR119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados. | |
| BRPI1013222B8 (pt) | composição que consiste em uma fração isolada de goma mastique obtida de pistacia lentiscus l. | |
| BR112015006055A2 (pt) | composições e métodos para o tratamento e prevenção de lesão tecidual e doença | |
| BR112012005044A2 (pt) | composições que compreendem tramadol e celecoxib no tratamento de dor. | |
| BR112013004436A2 (pt) | composições e usos de materiais com atividade microbicida alta e toxicidade baixa | |
| BR112014010376A2 (pt) | medicamento para o tratamento de doença do olho anterior que compreende rebamipida e um agente de retenção de lágrima | |
| BR112013011259A2 (pt) | condições de tratamento associadas com nível aumentado de eotaxina com 25-hidroxivitamina d3 | |
| BR112012007798A2 (pt) | microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas | |
| BR112014000634A2 (pt) | métodos para tratamento de incontinência associada com atividade sexual |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/01/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/06/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |